Abstract:OBJECTIVE:To study the inhibitory effect of small interference RNA (siRNA) targeting cyclin A2 gene on the growth of osteosarcoma MG-63 and human normal skin fibroblast HSF cells and to explore whether cyclin A2 siRNAs could become a useful tool in the treatment of osteosarcoma.METHODS:Three pairs of siRNAs targeting cyclin A2 mRNA and a pair of nonsense siRNA were designed according to the current criteria. SiRNAs were chemically synthesized and purified. The siRNAs were transfected into MG-63 cells and HSF cells via oligofectamine. The cells transfected with nonsense siRNA served as negative control group and those only treated with PBS as blank control group. Quantitative fluorescence RT-PCR, Western-blot, MTT assay, reverse transcriptase (RT)-PCR, flow cytometry and clone forming test were employed to evaluate the efficacy of RNA interference. At the same time, the mRNA expression of PCNA and cyclin B1 in siRNA-treated MG-63 cells were examined.RESULTS:Although all three siRNAs could reduce the cyclin A2 expression, siRNA, appeared to be the most effective. After 48 h treatment with siRNA1, cyclin A2 mRNA and protein expression in MG-63 cells was significantly reduced by nearly 80% as compared with that of the blank control group, whereas the negative and blank control groups had similar expression levels. MG-63 cells treated with siRNA1 were arrested at G0/G1 phase by 80.1% and the proliferation of these tumor cells was suppressed 48 h after transfection. Furthermore, MG-63 cells showed a decreased colony forming ability after siRNA1 treatment. In addition, the cyclin A2-depleted MG-63 cells showed decreased levels of PCNA and cyclin B1. In contrast, although cyclin A2 expression in HSF reduced by nearly 60% after treatment by siRNA1 for 48h, these cells exhibited only a slight change in cell cycling, and neither clear inhibition of proliferation nor impaired colony forming ability was observed.CONCLUSION:Cyclin A2 is critical for proliferation of MG-63 cells. Cyclin A2-siRNAs can induce obvious inhibition of cyclin A2 mRNA and protein expression in MG-63 and HSF cells, which consequently down-regulate the proliferation of MG-63 cells. There is little effect on the proliferation of siRNA-treated HSF cells. Those results indicate that siRNAs against cyclin A2 may become a potential antiproliferative tool in future antitumor therapy.

Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.

Silencing of Aurora Kinase A by RNA Interference Inhibits Tumor Growth in Human Osteosarcoma Cells by Inducing Apoptosis and G2/M Cell Cycle Arrest

MicroRNA-211 inhibits tumor growth and invasion through directly targeting RUNX 2 in osteosarcoma

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Knockdown of Aurora-B Alters Osteosarcoma Cell Malignant Phenotype Via Decreasing Phosphorylation of VCP and NF-κB Signaling

RNA Interference-Mediated Aurora Kinase A Gene Silencing Inhibits Human Glioma Cells Proliferation and Tumor Growth in Mice

Aurora B Kinase As a Novel Molecular Approach for Osteosarcoma Therapy

Aurora Kinase-B Silencing Promotes Apoptosis of Osteosarcoma 143B Cells by ULK1 Phosphorylation-Induced Autophagy

Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.

Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway

Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.

[Knockdown of Cyclin A2 Expression by Small Interfering RNA in MG-63 Cells].

Inhibition of Aurora-B Suppresses Osteosarcoma Cell Migration and Invasion

Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.

Silencing of Glucose Transporter Protein-1 by Rna Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in Vivo

Effects of Aurora A silence by RNA interference on the apoptosis and proliferation of glioma cells

RNAi-mediated Silencing of AQP1 Expression Inhibited the Proliferation, Invasion and Tumorigenesis of Osteosarcoma Cells

Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.

Let-7g Reverses Malignant Phenotype of Osteosarcoma Cells by Targeting Aurora-B.

Silencing XIAP Suppresses Osteosarcoma Cell Growth, and Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin and Cisplatin.